|
Number of entries related to HSC-3 cell line is 21 | GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 27002147
| | NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.28 | 0.5461 | 26448762
| | NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qRT-PCR followed by CFA | NA | 0.28 | 0.5461 | 22847005
| | POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 27002147
| | POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.28 | 0.6448 | 26448762
| | POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qRT-PCR followed by CFA | NA | 0.28 | 0.6448 | 22847005
| | SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 27002147
| | SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.28 | 0.5695 | 26448762
| | SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qRT-PCR followed by CFA | NA | 0.28 | 0.5695 | 22847005
| | KLF4 | 6348 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.2 | 0.0891 | 26448762
| | ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 29515788
| | ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | ALDEFLUOR assay followed by CFA | NA | 0.12 | 0.684 | 22847005
| | ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 26448762
| | ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by SFA | NA | 0.12 | 0.684 | 27002147
| | CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 0.456 | 30029671
| | CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 1 | 29515788
| | CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by CFA | NA | 0.12 | 1 | 22847005
| | CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by SFA | NA | 0.12 | 1 | 26448762
| | CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by SFA | NA | 0.12 | 1 | 27002147
| | CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 1 | 30029671
| | ITGB1 | 6153 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 0.018 | 30029671
|
|